NLRP3 and Alzheimer disease: Therefore, many studies have focused on inhibiting NLRP3 inflammasome activation in AD to suppress chronic neuroinflammation and improve brain function (Bai & Zhang, 2021; Feng et al., 2020; Lonnemann et al., 2020; Milner et al., 2021; Van Zeller et al., 2021).